A5103231487- Rheumatoid Arthritis Research and Therapies
- Autoimmune and Inflammatory Disorders Research
- Biosimilars and Bioanalytical Methods
- Leprosy Research and Treatment
- Immunodeficiency and Autoimmune Disorders
- Psychology and Mental Health
- Mycobacterium research and diagnosis
- Cardiac Arrest and Resuscitation
- Tuberculosis Research and Epidemiology
- Lymphoma Diagnosis and Treatment
- Water-Energy-Food Nexus Studies
- Trauma and Emergency Care Studies
- Pharmacovigilance and Adverse Drug Reactions
- Injury Epidemiology and Prevention
Universidade Federal do Pará
2023
UniBrasil Centro Universitário
2016
Universidade Federal de Mato Grosso do Sul
2013-2015
A DBS tem evoluído de uma abordagem para transtornos do movimento, como Parkinson, potencial terapia doenças neurodegenerativas, incluindo Alzheimer. Avanços tecnológicos, eletrodos direcionais e algoritmos estimulação, melhoraram a precisão reduziram efeitos adversos. Revisões sistemáticas ensaios clínicos indicam que pode modular circuitos cerebrais envolvidos na cognição memória, mas falta padronização nos parâmetros estimulação limita sua aplicabilidade. Enquanto estudos sugerem...
Chest trauma is one of the most common causes death, accounting for 20 to 25% cases. It can be blunt or penetrating trauma. Therefore, this work presents following guiding question: “What nursing role in caring patients undergoing use a chest tube? General objective: identify performance drainage. Method: This research consists an integrative literature review. Results: In searches articles databases and electronic magazines, 12 were found. Conclusion: The lack standardization care protocols...
<h3>Background</h3> Treatment survival of biological agents can be influenced by many factores. It seems to different between rheumatic disease. <h3>Objectives</h3> To compare the treatment disease analyze main causes discontinuation in patients with rheumatoid arthritis (RA) from Brazilian Registry – BIOBADABRASIL. <h3>Methods</h3> Cohort Society Biological Therapy Rheumatic Diseases (BIOBADABRASIL)including 2191 patients, including 1266 (57%) (RA), 678 (29.5%) spondyloarthritis 247 (12.5%)...
Introduction The detection of leprosy in children is an important epidemiological marker the disease, indicating community’s early exposure to Mycobacterium leprae and active transmission infection. Methods In order detect new cases among by combining clinical evaluation laboratory tests, we conducted case finding individuals under 15 years old on Caratateua Island, located city Belém, Pará state, endemic region Amazon. Dermato-neurological examination, collection 5 mL peripheral blood for...
<h3>Background</h3> The safety profile of a-TNF drugs might have regional differences due to socio economic factors and epidemiology infectious diseases. In 2009, the Brazilian Society Rheumatology started BiobadaBrasil registry, part a Latin America project (BiobadaAmerica) with methodological support SER Biobadaser <h3>Objectives</h3> To report incidence adverse events (AE) in patients exposed Brazil <h3>Methods</h3> Since 31 centers from 21/26 states included active rheumatic diseases...
<h3>Background</h3> The safety profile of biologic drugs might have substantial regional differences. Since 2009, the Brazilian Society Rheumatology runs BiobadaBrasil, a registry for monitoring therapies in rheumatic diseases, collaboration with other Latin America countries (BiobadaAmerica) and Biobadaser <h3>Objectives</h3> To report incidence serious adverse events (SAE) Rheumatoid Arthritis (RA) patients exposed to Brazil <h3>Methods</h3> BiobadaBrasil counts on thirty two centers, from...
<h3>Background</h3> The safety profile of biologic drugs might have substantial regional differences. Since 2009, the Brazilian Society Rheumatology runs BiobadaBrasil, a registry for monitoring therapies in rheumatic diseases, collaboration with other Latin America countries (BiobadaAmerica) and Biobadaser <h3>Objectives</h3> To report incidence serious infectious adverse events (SIAE) Rheumatoid Arthritis (RA) Spondyloarthritis (SpA) patients exposed to a-TNF Brazil <h3>Methods</h3>...
<h3>Objectives</h3> to analyse disease activity of RA patients at the start treatment with a biologic agent (adalimumab, infliximab, certolizumab, etanercept, golimumab, abatacept, rituximab and tocilizumab -bDMARDs), target (tofacitinib-tsDMARDs) therapy or conventional DMARDs (comparison cohort – csDMARDs). <h3>Methods</h3> BiobadaBrasil is prospective observational study, part an international initiative (biobadaAmerica) in collaboration BiobadaSeR; established 2009, ongoing study...